1.275
Standard Biotools Inc Azioni (LAB) Dati Finanziari
Conto economico
Trimestrale
*Tutti i numeri sono espressi in milioni
Data di fine periodo | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 |
Durata del periodo | 3 mesi | 3 mesi | 3 mesi | 3 mesi | 3 mesi |
Revenues |
46.66%
21.76
|
40.80 | 46.72 | 44.97 | 37.20 |
Cost Of Revenue |
47.12%
11.13
|
21.05 | 24.81 | 21.71 | 22.30 |
Gross Profit |
46.16%
10.63
|
19.74 | 21.91 | 23.26 | 14.91 |
|
31.09%
36.33
|
52.71 | 54.72 | 54.98 | 65.43 |
Benefits Costs and Expenses |
40.21%
40.04
|
66.98 | 80.52 | 71.79 | 82.87 |
Costs And Expenses |
40.21%
40.04
|
66.98 | 80.52 | 71.79 | 82.87 |
Operating Income/Loss |
22.06%
-25.70
|
-32.97 | -32.82 | -31.72 | -50.52 |
Income/Loss From Continuing Operations Before Tax |
30.18%
-18.28
|
-26.18 | -33.80 | -26.82 | -45.66 |
Income Tax Expense/Benefit |
303.31%
-0.609
|
-0.151 | 0.272 | 0.118 | 0.055 |
Income/Loss From Continuing Operations After Tax |
32.11%
-17.67
|
-26.03 | -34.07 | -26.94 | -45.72 |
Income/Loss From Discontinued Operations, Net Of Tax |
492.79%
-15.79
|
-2.663 | - | - | - |
|
28.53%
-33.46
|
-26.03 | -34.07 | -26.94 | -45.72 |
Preferred Stock Dividends And Other Adjustments |
-
|
- | - | - | - |
Attributable To Noncontrolling Interest |
-
|
- | - | - | - |
Basic Average Shares |
0.60%
380.50
|
378.23 | 7.152 | 371.54 | 372.33 |
Diluted Average Shares |
0.60%
380.50
|
378.23 | 7.152 | 371.54 | 372.33 |
Basic Earnings Per Share |
28.57%
-0.09
|
-0.07 | -0.08 | -0.07 | -0.12 |
Diluted Earnings Per Share |
28.57%
-0.09
|
-0.07 | -0.08 | -0.07 | -0.12 |
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic |
-
|
- | - | - | - |
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):